Helius Medical Technologies, Inc. announces impairment charges for the three months ended September 30 2023. For the quarter, the company reported Goodwill and fixed asset impairment of $159,000 against $757,000 a year ago.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | +1.35% | -12.54% | -44.02% |
Apr. 24 | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | CI |
Apr. 03 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.02% | 3.99M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Announces Impairment Charges for the Three Months Ended September 30 2023